Anteroposterior Gradients in Cerebral Glucose Use in Schizophrenia and Affective Disorders

Archives of General Psychiatry

Volumn 41, Issue 12, 1984, Pages 1159-1166

  Buchsbaum, Monte S ^a   Delisi, Lynn E ^b   Holcomb, Henry H ^b   Cappelletti, John ^b   King, Anna Catherine ^b   Johnson, Jeannette ^b   Hazlett, Erin ^a   Dowling Zimmerman, Susan ^b   Post, Robert M ^b   Morihisa, John ^b   Carpenter, William ^c   Cohen, Robert ^b   Pickar, David ^b   Weinberger, Daniel R ^b   Margolin, Richard ^d   Kessler, Robert M ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

ADULT; AFFECTIVE NEUROSIS; BRAIN SLICE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COMPUTER ANALYSIS; CYTOLOGY; DIAGNOSIS; GLUCOSE BRAIN LEVEL; HUMAN; HUMAN EXPERIMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; BRAIN; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DEOXYGLUCOSE; DEPRESSIVE DISORDER; DOMINANCE, CEREBRAL; ELECTRIC STIMULATION; FEMALE; FLUORINE; FUNCTIONAL LATERALITY; GLUCOSE; HUMANS; MALE; PAIN; RADIOISOTOPES; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0021747252     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1984.01790230045007     Document Type: Article

References (41)

1. Sokoloff L: Relationships among local functional activity, energy metabolism and blood flow in the central nervous system. Fed Proc 1981;40:2311-2316.
2. Ingvar DH, Franzen G: Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974;50:425-462.
3. Flor-Henry P, Gruzelier J (eds): Laterality and Psychopathology, Amsterdam, North-Holland Publishing Co, 1983.
4. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, King AC, Johnson JL, Manning RF, Flynn RW, Mann LS, Bunney WE Jr, Sokoloff L: Cerebral glucography with positron tomography. Arch Gen Psychiatry 1982;39:251-259.
5. Farkas T, Reivich M, Alavi A, Greenberg JH, Fowler JS, MacGregor RR, Christman DR, Wolf AP: The application of [18FJ2-deoxy-2-fluoro-Dglucose and positron emission tomography in the study of psychiatric conditions, in Passonnean JV, Hawkins RA, Lust WD, et al (eds): Cerebral Metabolism and Neural Function. Baltimore, Williams & Wilkins Co, 1980, pp 403-408.
6. Widen L, Bergstrom M, Blomquist C: Glucose metabolism in patients with schizophrenia: Emission computed tomography measurements with 11-C-glucose. Read before the International Congress of Biological Psychiatry, Stockholm, July 1, 1981.
7. Ingvar DH, Rosen I, Elmqvist D: Effects of somatosensory stimulation upon rest, in Harper M, Jennett B, Miller D, Rowan J (eds): Blood Flow and Metabolism in the Brain: Proceedings of the Seventh International Symposium on Cerebral Blood Flow and Metabolism. New York, Churchill Livingstone, 1975.
8. Ingvar DH, Rosen I, Eriksson M, Elmqvist D: Activation patterns induced in the dominant hemisphere by skin stimulation, in Zotterman Y (ed): Sensory Functions of the Skin. New York, Pergamon Press, 1976, pp 549-559.
9. Tsubokawa T, Katayama Y, Ueno Y, Moriyasu N: Evidence for involvement of the frontal cortex in pain-related cerebral events in cats: Increase in local cerebral blood flow by noxious stimuli. Brain Res 1981;217:179-185.
10. Davis GC, Buchsbaum MS: Pain sensitivity and endorphins in funetional psychoses, in Ban TA, Freyhan FA, Ichot PP, Poldinger W (eds): Modern Problems of Pharmacopsychiatry. New York, S Karger AG, 1981, pp 97-108.
11. Pickar D, Vartanian F, Bunney WE Jr, Maier HP, Gastpar MT, Prakash R, Sethi BB, Lideman R, Belyaev BS, Tsutsulkovskaja MV, Jungkunz G, Nedopil N, Verhoeven W, van Praag H: Short-term naloxone administration in schizophrenic and manic patients. Arch Gen Psychiatry 1982;39:313-319.
12. Davis GC, Buchsbaum MS, van Kammen DP, Bunney WE Jr: Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone. Psychiatry Res 1979;1:61-69.
13. Buchsbaum MS, Davis GC, Coppola R, Naber D: Opiate pharmacology and individual differences: II. Somatosensory evoked potentials. Pain 1981;10:367-377.
14. Buchsbaum MS, Davis GC, Bunney WE Jr: Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature 1977;270:620-622.
15. Davis GC, Buchsbaum MS, Bunney WE Jr: Alterations of evoked potentials link research in attention dysfunction to peptide response symptoms of schizophrenia, in Costa E, Trabucchi M (eds): Neural Peptides and Neuronal Communications. New York, Raven Press, 1980, pp 473-487.
16. American Psychiatric Association, Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.
17. Endicott J, Spitzer RL: A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978;35:837.
18. Wing JK, Cooper JE, Sartorius N: Present State Examination. Cambridge, Mass, Cambridge University Press, 1973.
19. Bunney WE Jr, Hamburg DA: Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 1963;9:280-294.
20. Buchsbaum MS, Holcomb HH, Kessler R, Johnson J, King AC, Cappelletti J, Bisserbe JC, van Kammen DP, Selub S, Wu J, Manning RG, Channing M: Lateralized asymmetries in glucose uptake assessed by positron emission tomography in patients with schizophrenia and normal controls, in Flor-Henry P, Gruzelier J (eds): Laterality and Psychopathology. Amsterdam, North-Holland Publishing Co, 1983, vol 2.
21. Buchsbaum MS, Cappelletti J, Ball R, Hazlett E, King AC, Johnson J, Wu J, DeLisi LE: PET image measurement in schizophrenia and affective disorders. Ann Neurol 1984;15(suppl)S157-S165.
22. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE: Tomographic measurement of local cerebral glucose metabolic rate in humans with [F-18] 2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 1979;6:371-388.
23. Buchsbaum MS, Davis GC, Coppola R, Naber D: Opiate pharmacology and individual differences: I. Psychophysical pain measurement. Pain 1981;10:357-366.
24. Spielberger CD, Gorsuch Rl, Lushene RE: Manual for the State-Trait Anxiety Inventory, Palo Alto, Calif, Consulting Psychologist Press, 1970.
25. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M: The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
26. Dixon WJ: MDP Statistical Software. Berkeley, Calif, University of California Press, 1981, pp 388-412.
27. Buchsbaum MS, Holcomb HH, Johnson J, King AC, Kessler R: Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals. Hum Neurobiol 1983;2:35-38.
28. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE: Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:69-82.
29. Mathew RJ, Duncan GC, Weinman ML, Barr DL: Regional cerebral blood flow in schizophrenia. Arch Gen Psychiatry 1982;39:1121-1124.
30. Ariel RN, Golden CJ, Berg RA, Quaife MA, Dirksen JW, Forsell T, Wilson J, Graber B: Regional cerebral blood flow in schizophrenics. Arch Gen Psychiatry 1983;40:258-263.
31. Ingvar DH, Philipson L: Distribution of cerebral blood flow in the dominant hemisphere during motor ideation and motor performance. Ann Neurol 1977;2:230-237.
32. Mazziotta JC, Phelps ME, Miller J, Kuhl DE: Tomographic mapping of human cerebral metabolism: Normal unstimulated state. Neurology 1981;31:503-516.
33. Reivich M, Alavi A, Wolf A, Greenberg JH, Fowler J, Christman D, MacGregor R, Jones SC, London J, Shiue C, Yonekura Y: Use of 2-deoxy-D[1-11C] glucose for the determination of local cerebral glucose metabolism in humans: Variation within and between subjects. J Cereb Blood Flow Metabol 1982;2:307-319.
34. Buchsbaum MS, Cappelletti J, Coppola R, Regal F, King AC, van Kammen DP: New methods to determine CNS effects of antigeriatric compounds: EEG topography and glucose use. Drug Dev Res 1982;2:489-496.
35. Morihisa JM, Duffy FH, Wyatt RJ: Brain electrical activity mapping (BEAM) in schizophrenic patients. Arch Gen Psychiatry 1983;40:719-728.
36. Reivich M, Gur R, Alavi A: Positron emission tomographic studies of sensory stimuli, cognitive processes and anxiety. Hum Neurobiol 1983;2:25-33.
37. Freedman DX (ed): Biology of the major psychoses: A comparative analysis. Res Publ Assoc Res Nerv Ment Dis 1975;54:vii-viii.
38. Meltzer HY: What is schizophrenia. Schizophr Bull 1982;8:433-434.
39. Mazziotta JC, Phelps ME, Plummer D, Quantification in positron emission tomography: Five physical-anatomical effects. J Comput Assist Tomogr 1981;5:734-743.
40. Morrison JH, Molliver ME, Grzanna R: Noradrenergic innervation of cerebral cortex: Widespread effects of local cortical lesions. Science 1979; 205:313-316.
41. Tassin JP, Cheramy A, Thierry AM, Glowinski J: Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum: I. Microestimation of [3H] dopamine uptake and dopamine content in microdiscs. Brain Res 1976;107:291-301.